AU564570B2 - Topical pharmaceutical compositions - Google Patents

Topical pharmaceutical compositions

Info

Publication number
AU564570B2
AU564570B2 AU82334/82A AU8233482A AU564570B2 AU 564570 B2 AU564570 B2 AU 564570B2 AU 82334/82 A AU82334/82 A AU 82334/82A AU 8233482 A AU8233482 A AU 8233482A AU 564570 B2 AU564570 B2 AU 564570B2
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
topical
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU82334/82A
Other versions
AU8233482A (en
Inventor
Joachim Franz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/en
Priority claimed from CH2631/81A external-priority patent/CH647149A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU8233482A publication Critical patent/AU8233482A/en
Application granted granted Critical
Publication of AU564570B2 publication Critical patent/AU564570B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU82334/82A 1981-04-06 1982-04-05 Topical pharmaceutical compositions Ceased AU564570B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH2327/81 1981-04-06
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81 1981-04-22
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH3278/81 1981-05-20
CH327881 1981-05-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU65084/86A Division AU6508486A (en) 1981-04-06 1986-11-12 Pharmaceutical tizanidine compositions

Publications (2)

Publication Number Publication Date
AU8233482A AU8233482A (en) 1982-10-14
AU564570B2 true AU564570B2 (en) 1987-08-20

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82334/82A Ceased AU564570B2 (en) 1981-04-06 1982-04-05 Topical pharmaceutical compositions

Country Status (16)

Country Link
AU (1) AU564570B2 (en)
CA (1) CA1192496A (en)
DE (1) DE3212053A1 (en)
DK (1) DK155882A (en)
ES (1) ES8308698A1 (en)
FI (1) FI821123L (en)
FR (1) FR2502951B1 (en)
GB (2) GB2098865B (en)
GR (1) GR75462B (en)
IL (1) IL65424A0 (en)
IT (1) IT8220611A0 (en)
MY (1) MY8600571A (en)
NL (1) NL8201413A (en)
NZ (1) NZ200232A (en)
PT (1) PT74703B (en)
SE (1) SE8202172L (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (en) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (en) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner HIGHLY DISPERSAL PHARMACEUTICAL MULTI-COMPONENT SYSTEMS AND METHOD FOR THEIR PRODUCTION
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
WO1985003878A1 (en) * 1984-03-01 1985-09-12 Sandoz Ag Pharmaceutical compositions
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (en) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk Anti-inflammatory and analgesic application agent
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (en) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate for the inhibition of acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (en) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh HIGH DISPERSES PHARMACEUTICAL COMPOSITION
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
IE921212A1 (en) * 1991-04-19 1992-10-21 Affinity Biotech Inc Convertible microemulsion formulations
HU223343B1 (en) * 1991-05-20 2004-06-28 Novartis Ag. Compositions comprising allylamine derivatives, and process for their preparation
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (en) * 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ES2098739T3 (en) 1992-05-13 1997-05-01 Sandoz Ltd OPHTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN.
EP1142568A1 (en) 1992-09-25 2001-10-10 Novartis AG Pharmaceutical compositions containing cyclosporins
EP0671937A4 (en) * 1992-10-16 1996-09-18 Smithkline Beecham Corp Pharmaceutical emulsion compositions.
WO1994019000A1 (en) * 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions containing pharmaceutical compositions
KR970704464A (en) 1994-11-03 1997-09-06 가이슐러 에리히, 데커 카를-루드빅 A novel cyclosporin formulation for oral administration having a simple composition and high biological efficacy and a method for producing the same. (Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability,
DE4442999A1 (en) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmaceutical composition containing an active loratidine metabolite
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
IN188719B (en) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
UY25225A1 (en) 1997-10-29 2000-12-29 Smithkline Beecham Plc PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (en) * 1998-06-10 1999-12-16 Labtec Gmbh New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion
IL143580A0 (en) * 1998-12-11 2002-04-21 Pharmasolutions Inc Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1644004A4 (en) * 2003-06-20 2010-10-06 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
ATE474591T1 (en) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INSULIN TREATMENT
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
MX2018011705A (en) 2016-04-01 2019-06-10 Therapeuticsmd Inc Steroid hormone pharmaceutical composition.
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (en) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (en) * 1977-01-14 1982-09-30 Sandoz Ag Method for producing new heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
DE3212053A1 (en) 1982-10-21
NZ200232A (en) 1985-08-16
IT8220611A0 (en) 1982-04-06
GB2148711A (en) 1985-06-05
PT74703B (en) 1984-05-30
ES511169A0 (en) 1983-10-01
FR2502951A1 (en) 1982-10-08
NL8201413A (en) 1982-11-01
GR75462B (en) 1984-07-20
GB2098865B (en) 1985-12-18
SE8202172L (en) 1982-10-07
ES8308698A1 (en) 1983-10-01
FI821123A0 (en) 1982-03-31
MY8600571A (en) 1986-12-31
PT74703A (en) 1982-05-01
AU8233482A (en) 1982-10-14
GB2148711B (en) 1985-12-18
CA1192496A (en) 1985-08-27
FI821123L (en) 1982-10-07
FR2502951B1 (en) 1985-12-06
DK155882A (en) 1982-12-10
IL65424A0 (en) 1982-07-30
GB8408654D0 (en) 1984-05-16
GB2098865A (en) 1982-12-01

Similar Documents

Publication Publication Date Title
AU564570B2 (en) Topical pharmaceutical compositions
AU544969B2 (en) Topical pharmaceutical compositions
AU555915B2 (en) Lipip compositions
AU535604B2 (en) Pharmaceutical compositions
AU3503984A (en) Pharmaceutical compositions
AU549070B2 (en) Nalbuphine-narcotic analgesic composition
AU4454389A (en) Pharmaceutical composition
AU526912B2 (en) Pharmaceutical composition
AU535605B2 (en) Pharmaceutical compositions
AU1459183A (en) Anti-ulcer pharmaceutical composition
AU558670B2 (en) Pharmaceutical compositions
AU6501980A (en) Pharmaceutical compositions
AU4430685A (en) Topical compositions
AU523405B2 (en) Pharmaceutical compositions
ZA822357B (en) Topical pharmaceutical compositions
HK91387A (en) Pharmaceutical compositions
AU7172381A (en) Medicinal composition
AU578657B2 (en) Pharmaceutical compositions
AU7997382A (en) Haemobiologic composition
MY8600640A (en) Topical pharmaceutical compositions
IL81538A0 (en) Topical pharmaceutical compositions
AU534571B2 (en) Pharmaceutical compositions
AU543418B2 (en) Pharmaceutical formulation
AU543343B2 (en) Epoxy-imide composition
IL64208A0 (en) Topical pharmaceutical composition